The curve of tumor volume over time demonstrated a clear trend: the control group experienced a continual increase in tumor size, whereas the growth of tumors in treatment groups was suppressed to varying extents.
← all excerpts
Structure-guided screening identifies Tucatinib as dual inhibitor for MCT1/2.
1
—
—